UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028083 |
|---|---|
| Receipt number | R000031964 |
| Scientific Title | Phase I study of WT1-expressing human artificial adjuvant vector cells (aAVC-WT1) for patients with relapsed or refractory acute myeloid leukemia |
| Date of disclosure of the study information | 2017/07/05 |
| Last modified on | 2020/06/11 15:42:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/07/05 15:42:00 | ||
| 2 | Update | 2017/09/26 14:29:29 | UMIN ID1 UMIN ID2 |
|
| 3 | Update | 2017/12/06 12:07:47 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2018/05/14 12:03:41 | Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2018/05/14 12:06:25 | Last name of lead principal investigator Last name of lead principal investigator Name of person sending information Name of person sending information |
|
| 6 | Update | 2018/06/20 14:01:05 | UMIN ID3 |
|
| 7 | Update | 2020/06/11 15:08:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 8 | Update | 2020/06/11 15:39:03 | Recruitment status Date of IRB Last follow-up date |
|
| 9 | Update | 2020/06/11 15:42:41 | Number of participants that the trial has enrolled |
